Vimarsana
Biggest News Aggregation in the World

Page 23 - Default Announcement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Default Announcement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Default Announcement Today - Breaking & Trending Today

World Class Extractions Inc. Provides Bi-Weekly Status Report - Vimarsana News

World Class Extractions Inc. Provides Bi-Weekly Status Report

Vancouver, British Columbia--(Newsfile Corp. - September 13, 2022) - World Class Extractions Inc. (CSE: PUMP) (FSE: WCF) (OTCQB: WCEXF) (the "Corporation" or "World-Class") is providing this bi-weekly

I3 Interactive Inc.: i3 Interactive Inc. Provides MCTO Status Update - Vimarsana News

I3 Interactive Inc.: i3 Interactive Inc. Provides MCTO Status Update

Toronto, Ontario--(Newsfile Corp. - August 29, 2022) - i3 Interactive Inc. (CSE: BETS) (the "Corporation") is providing a status update on its temporary management cease trade order (the "MCTO"). On June

I3 Interactive Inc.: i3 Interactive Inc. Provides Bi-Weekly Status Report - Vimarsana News

I3 Interactive Inc.: i3 Interactive Inc. Provides Bi-Weekly Status Report

Toronto, Ontario--(Newsfile Corp. - August 24, 2022) - i3 Interactive Inc. (CSE: BETS) (the "Corporation") is providing this bi-weekly default status report (the "Default Status Report") in accordance

Arctic Glacier Issues Default Status Report Pursuant to - Vimarsana News

Arctic Glacier Issues Default Status Report Pursuant to

WINNIPEG, Manitoba, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Arctic Glacier Income Fund (CSE: AG.UN) (the “Fund”) is providing a default status report, in...

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update - Vimarsana News

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is providing a bi-weekly default status update in accordance with National Policy 12-203 – Management Cease Trade Orders (“NP 12...